益佰制药(600594) - 2018 Q1 - 季度财报

Financial Performance - Operating revenue for the period was CNY 963,846,291.14, representing a 3.53% increase year-on-year[6] - Net profit attributable to shareholders increased by 4.41% to CNY 97,464,207.66 compared to the same period last year[6] - Basic and diluted earnings per share were both CNY 0.128, a slight increase of 0.79% compared to the previous year[6] - Total revenue for Q1 2018 was CNY 963.85 million, an increase of 3.9% compared to CNY 930.95 million in the same period last year[23] - Net profit for Q1 2018 was CNY 106.28 million, a decrease of 8.0% from CNY 115.53 million in Q1 2017[24] - Earnings per share for Q1 2018 were CNY 0.128, slightly up from CNY 0.127 in the previous year[25] - The company’s total comprehensive income for Q1 2018 was CNY 25,260,032.72, reflecting a decrease from CNY 37,977,303.93 in the previous year[27] Asset and Liability Changes - Total assets increased by 3.44% to CNY 7,442,224,288.23 compared to the end of the previous year[6] - Total assets as of March 31, 2018, were 7,442,224,288.23, an increase from 7,194,494,634.45 at the beginning of the year[17] - Current assets totaled 2,704,309,076.47, up from 2,652,614,527.77 at the beginning of the year[16] - Total liabilities increased to 2,643,488,473.22 from 2,505,610,751.00, reflecting a rise in short-term borrowings[18] - Total liabilities increased to CNY 2.40 billion in Q1 2018, up from CNY 2.32 billion in Q1 2017, representing a rise of 3.5%[22] Cash Flow Analysis - Cash flow from operating activities showed a significant decline of 151.73%, resulting in a net cash outflow of CNY -154,209,766.34[6] - Cash flow from operating activities was -154,209,766.34, a decrease of -151.73% compared to 298,100,170.76, primarily due to slower sales collection[14] - Cash flow from investing activities was -109,826,519.96, an increase of 76.08% compared to -62,374,276.65, mainly due to payments for equity in Fulin Hospital[14] - Operating cash flow for Q1 2018 was negative CNY 154,209,766.34, compared to a positive CNY 298,100,170.76 in Q1 2017[29] - Investment activities resulted in a net cash outflow of CNY 109,826,519.96, compared to a net outflow of CNY 62,374,276.65 in the same period last year[30] - Financing activities generated a net cash inflow of CNY 21,300,884.24, an increase from CNY 9,007,659.03 in Q1 2017[30] Receivables and Payables - Accounts receivable increased by 71.52% to CNY 656,119,605.73, attributed to slower sales collection[11] - Prepayments rose by 44.19% to CNY 53,004,971.63 due to increased project payments[11] - Other receivables increased by 64.91% to CNY 136,166,065.59, mainly due to increased advances to counterparties[11] - Interest payable surged by 165.64% to CNY 15,378,303.83, primarily due to increased interest accrual on bonds[11] Investment and Income Changes - Investment income decreased to 0.00 from -394,876.37, a change of -100.00% due to unrecognized investment losses[13] - Other income increased to 4,247,778.95 from 0.00, a change of 100.00% due to adjustments in financial reporting format[13] - Operating income decreased to 1,133,720.29 from 10,060,290.15, a change of -88.73% attributed to reduced non-operating expenses[13] Cost Management - Total operating costs for Q1 2018 were CNY 845.94 million, up 4.5% from CNY 809.50 million in Q1 2017[24] - The company reported a decrease in sales expenses to CNY 453.19 million from CNY 433.16 million, reflecting a strategic focus on cost management[24] - The company incurred total operating expenses of CNY 1,037,873,286.06, an increase from CNY 927,747,737.99 in the previous year[29] Equity and Capital Structure - The company has maintained a stable capital structure with total equity at CNY 3.77 billion, slightly up from CNY 3.74 billion in the previous year[22] - Minority interest decreased to 417,385,316.33 from 408,855,401.93, a change of -2.00% due to changes in the consolidation scope[18] Cash and Liquidity - Cash and cash equivalents decreased to 950,778,514.09 from 1,165,547,188.51, indicating a reduction in liquidity[16] - The cash and cash equivalents at the end of Q1 2018 were CNY 1,257,299,363.09, down from CNY 1,521,715,042.81 at the end of Q1 2017[30] - The company paid CNY 263,149,389.20 to employees in Q1 2018, significantly higher than CNY 112,495,805.40 in the same period last year[29]